- Home
- MASS vs CERS Comparison
MASS vs CERS Comparison
Compare MASS & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASS
- CERS
- Stock Information
- Founded
- MASS 2012
- CERS 1991
- Country
- MASS United States
- CERS United States
- Employees
- MASS N/A
- CERS N/A
- Industry
- MASS Medical/Dental Instruments
- CERS EDP Services
- Sector
- MASS Health Care
- CERS Technology
- Exchange
- MASS Nasdaq
- CERS Nasdaq
- Market Cap
- MASS 235.8M
- CERS 255.0M
- IPO Year
- MASS 2020
- CERS 1997
- Fundamental
- Price
- MASS $6.82
- CERS $1.30
- Analyst Decision
- MASS Strong Buy
- CERS Strong Buy
- Analyst Count
- MASS 3
- CERS 2
- Target Price
- MASS $8.00
- CERS $3.50
- AVG Volume (30 Days)
- MASS 294.7K
- CERS 1.1M
- Earning Date
- MASS 11-11-2025
- CERS 10-29-2025
- Dividend Yield
- MASS N/A
- CERS N/A
- EPS Growth
- MASS N/A
- CERS N/A
- EPS
- MASS N/A
- CERS N/A
- Revenue
- MASS $65,560,000.00
- CERS $192,510,000.00
- Revenue This Year
- MASS N/A
- CERS $22.02
- Revenue Next Year
- MASS $22.29
- CERS $9.32
- P/E Ratio
- MASS N/A
- CERS N/A
- Revenue Growth
- MASS 37.93
- CERS 13.25
- 52 Week Low
- MASS $1.81
- CERS $1.12
- 52 Week High
- MASS $8.06
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- MASS 63.93
- CERS 52.56
- Support Level
- MASS $5.52
- CERS $1.17
- Resistance Level
- MASS $5.83
- CERS $1.27
- Average True Range (ATR)
- MASS 0.34
- CERS 0.06
- MACD
- MASS 0.13
- CERS 0.00
- Stochastic Oscillator
- MASS 89.82
- CERS 72.22
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.